Research for treatments, prevention and a cure
DEBUG INFO [ON]
Page template: single-clinical-trials.php
Search terms : 

Clinical Trials

  • Clinical Studies

Clinical Care and Management (CCM)


CTN 238: The MAINTAIN study

A randomized control clinical trial of micronutrient and antioxidant supplementation in persons with untreated HIV infection

Print Friendly, PDF & Email

About the study

This study will examine if supplementation of a specially enhanced micronutrient preparation, compared to standard vitamins, can slow disease progression or delay the start of ARVs in asymptomatic adults currently not needing nor taking ARVs. Researchers will examine the safety and effect of the supplement on participants’ health and well-being over two years. This is a three-year study recruiting 218 participants from The Ottawa Hospital and participating CTN sites.

Participants will be randomly assigned to one of the two following equal groups:
• Group A (experimental arm): Participants will receive an oral micronutrient antioxidant preparation daily (K-PAX Ultra®)
• Group B (control arm): Participants will receive identical appearing standard multivitamins (Centrum-like)

Study Approach

Each group will take 8 capsules twice daily with food. Neither the participant nor the doctor will know which treatment is being administered. Though the role of supplementation remains unclear, some studies show that supplementation of micronutrient antioxidants may help protect an individual’s immunity and health. This is important because even in the early stage of HIV infection, persons commonly experience lower blood levels of micronutrients (vitamins and minerals) which may increase the risk of disease progression to AIDS.

Preliminary Results

Study researchers measured how well the trial participants were adhering to the treatment regimens using pill counts and two self-reported measurement scales. Treatment adherence was found to be high in the study group, over 80%. Preliminary analysis of micronutrient levels in blood samples showed that micronutrient deficiencies were common in study participants.

Additional Information

If you would like more information on this clinical study, please refer to clinicaltrials.gov.

Principal Investigator

Dr. Bill Cameron,
The Ottawa Hospital
Ph: 613-737-8209

 

Publications:

Singhal N, Fergusson D, Huff H, Mills EJ, la Porte C, Walmsley SL, Cameron DW. Design and methods of the MAINTAIN study: a randomized controlled clinical trial of micronutrient and antioxidant supplementation in untreated HIV infection. Contemporary clinical trials. 2010 Nov;31(6):604-611.

Balfour L, Spaans JN, Fergusson D, Huff H, Mills EJ, la Porte CJ, Walmsley SL, Singhal N, Rosenes R, Tremblay N, Gill MJ, Loemba H, Conway B, Rachlis A, Ralph E, Loutfy MR, Mallick R, Moorhouse R, Cameron DW. Micronutrient deficiency and treatment adherence in a randomized controlled trial of micronutrient supplementation in ART-naïve persons with HIV. PLOS ONE. 2014 Jan;9(1):e85607.

Latest News

Guest Blog: Dr. Hudson Reddon

| Uncategorized | No Comments

Dr. Hudson Reddon, CTN Postdoctoral Fellow, discusses his project which aims to describe the effect of cannabis legalization on injection drug use and HIV risk.

CTN at the 2019 IAS Conference on HIV Science

| Uncategorized | No Comments

The 10th International AIDS Society Conference on HIV Science – known as IAS 2019 – will take place on July…

Government of Canada invests close to $23M in HIV/AIDS research

| Uncategorized | No Comments

Investment will support research on prevention, treatment, and developing a cure for HIV.

Aging with HIV

| Uncategorized | No Comments

Today, more than half of all people living with HIV in Canada are 50 years or older. This is mostly because people are living much longer, healthier lives with HIV thanks to the success of antiretroviral therapy (ART).

Research for treatments, prevention and a cure